印度傳統醫學市場評估:依衛生系統,子行業,原產地,應用,給藥途徑,分銷管道,地區,機會,預測2017-2031 年

2023年印度傳統醫藥市場規模為275.3億美元。預計到 2031 年，該市場將達到 731.9 億美元，2024 年至 2031 年的預測期間複合年增長率為 13%。印度傳統醫學市場成長的主要驅動力是傳統醫學的成本效益、與患者個人信仰的一致性、減輕對合成藥物潛在副作用的擔憂、滿足個性化醫療的需求以及促進福祉。到它是天然和安全的，以及綜合醫學研究支持的某些草藥療法的有效性和安全性。

印度傳統醫藥市場的擴張植根於多種因素的複雜相互作用，這些因素與患者和醫療保健部門產生了深刻的共鳴。根本驅動力是傳統醫療實務固有的成本效益。許多治療方法依賴現成的草藥和植物的治癒能力，因此比合成藥物更經濟。這種負擔能力對於像印度這樣的多元化國家尤其有利，因為在印度，獲得醫療保健對某些人群來說可能是一個課題。

此外，傳統藥物天然且安全的觀念極大地促進了印度傳統藥物市場需求的成長。許多人相信草藥源自於自然。整合醫學研究進一步增強了這種信心，該研究提供了支持特定草藥療法的有效性和安全性的經驗證據。例如，薑黃因其抗發炎特性而獲得全球認可，科學研究也證實了其眾多的健康益處。

總之，印度傳統醫藥市場的擴張是由經濟、文化、安全和知識驅動因素協同所推動的。這些因素共同使傳統醫學成為該國醫療保健的一個組成部分，滿足人民的多樣化需求和偏好。

本報告調查了印度傳統醫學市場，並依醫療系統、分行業、原產地、應用、給藥途徑、分銷渠道、地區和進入市場的公司對市場進行了概述。

目錄

第一章研究方法論

第二章 專案範圍與定義

第三章執行摘要

第四章 2017-2031 年印度傳統醫藥市場前景

• 市場規模及預測
• 依醫療系統
• 依界別分組
• 依產地
• 依用途
• 依給藥途徑
• 依分銷渠道
• 依地區
• 依公司劃分的市佔率 (%)，2023 年

第 6 章 市場測繪，2023 年

第七章 宏觀環境與產業結構

• 供需分析
• 進出口分析
• 價值鏈分析
• PESTEL 分析
• 波特五力分析

第八章市場動態

第九章 監理架構與創新

第十章 主要與企業狀況

第11章價格分析

第十二章案例研究

第十三章 主要進入者展望

• Himalaya Wellness Company
• Dabur India Ltd.
• Patanjali Ayurved Ltd.
• Shree Baidyanath Ayurved Bhawan Pvt. Ltd.
• Hamdard Laboratories
• Dr. Reckeweg & Co.
• Dr Willmar Schwabe India Pvt. Ltd.
• Ayyebi Dawakhana Unani Pvt. Ltd.
• SBL Pvt. Ltd.
• Hahnemann Scientific Laboratory
• Tamil Nadu Medicinal Plant Farms and Herbal Medicine Corporation Ltd.
• The Indian Medical Practitioners Co-operative Pharmacy and Stores Ltd.

第十四章 戰略建議

第十五章 查詢及免責聲明

India traditional medicine market size was valued at USD 27.53 billion in FY2023, which is expected to reach USD 73.19 billion in FY2031, with a CAGR of 13% for the forecast period between FY2024 and FY2031. The primary drivers behind the growth of India traditional medicine market include cost-effectiveness of traditional medicines, alignment with the patient's personal beliefs, alleviation of concerns about the potential side effects of synthetic drugs, fulfilment of a desire for individualized healthcare, facilitation of broader public access to health knowledge, prevalent perception of being both natural and safe, and the efficacy and safety of certain herbal remedies being backed by integrative health research.

The expansion of India traditional medicine market is rooted in a complex interplay of factors that deeply resonate with both patients and the healthcare sector. A fundamental driving force is the cost-effectiveness inherent in traditional medicinal practices. Many remedies harness the healing power of readily available herbs and plants, rendering them more economically accessible than synthetic pharmaceuticals. This affordability is especially advantageous in a nation as diverse as India, where healthcare access can pose challenges for certain demographics.

Furthermore, the perception of traditional medicines as being natural and safe significantly contributes to the growing demand in India's traditional medicine market. Many individuals trust herbal remedies due to their origins in the natural world. The trust is further reinforced by integrative health research, which provides empirical evidence supporting the effectiveness and safety of specific herbal treatments. For example, turmeric has received global recognition for its anti-inflammatory properties, with scientific studies validating its numerous health benefits.

In essence, the expansion of India's traditional medicine market is propelled by the synergy of economic, cultural, safety, and knowledge-driven elements. These elements collectively establish traditional medicine as an indispensable component of the nation's healthcare landscape, catering to its population's diverse needs and preferences.

Increasing Prevalence of Chronic Diseases

The prevalence of chronic diseases in India has been steadily increasing, posing a significant public health challenge. Studies have revealed high rates of diabetes and hypertension across the country, with diabetes affecting more than 100 million people and hypertension accounting for more than 188.3 million people. Notably, among 18 to 25-year-olds, the prevalence of hypertension is as high as 12%. These conditions are more prevalent in urban areas and worse among the elderly. The burden of chronic diseases is particularly pronounced in urban areas, where 29% of the elderly are affected, compared to 17% in rural areas. Hypertension and diabetes account for a substantial proportion of chronic diseases, with heart disease, acute upper respiratory tract disease, asthma, and stroke contributing to the overall prevalence.

The increasing prevalence of chronic diseases in India has contributed to a rising demand for traditional medicines. Traditional medicines, especially Ayurveda, have gained popularity in India and amidst other countries. The market for medicinal plants in India is growing, with a significant increase in demand for herbal and value-added extracts of medicinal herbs, both domestically and in foreign markets.

Growing Desire for Individualized Healthcare

The desire for individualized healthcare has caused a great surge in India's traditional medicine market. The traditional medicinal systems provide a customized healthcare approach that considers an individual's unique constitution, lifestyle, and health requirements. In contrast to the one-size-fits-all approach of modern medicine, traditional systems like Ayurveda recognize the distinctiveness of each person and the necessity for a personalized treatment regime. These systems often evaluate a patient's physical, mental, and emotional well-being, including diet, environment, and personality traits. By prioritizing individualized care, traditional medicines target specific ailments and strive to enhance overall balance and well-being. The comprehensive approach appeals to many individuals seeking a more tailored and holistic healthcare experience.

Heightened Emphasis on Integrative Health Research

Increased focus on integrative medicine research contributes to the expansion of India traditional medicine market. There is a rising acknowledgment of integrative medicine's potential benefits as individuals seek holistic healthcare solutions. Both patients and healthcare professionals are growing interested in blending conventional medical practices with complementary therapies to create well-rounded and personalized treatment strategies. Consequently, research in the field is crucial for validating these assertions and guaranteeing safety, effectiveness, and seamless integration of evidence-based techniques into mainstream healthcare systems, ultimately leading to improved patient outcomes. In May 2023, The Ministry of Ayush and Indian Council of Medical Research (ICMR) inked a Memorandum of Understanding (MoU) to foster and jointly engage in integrative health research. The MoU is centered on prioritized areas of national significance in healthcare and aims to stimulate impactful research that generates evidence using contemporary scientific methodologies. The collaboration will enhance research capabilities by providing training opportunities for Ayush researchers.

Government Initiatives

A significant portion of the accolades for the expansion of India traditional medicine market can be attributed to the Indian government, which has undertaken numerous initiatives to foster traditional medicine systems. India has entered into international agreements and partnerships to advance traditional medicine on a global scale, exemplified by Memorandums of Understanding (MoU) with nations like the United States and Russia, fostering collaborative research and exchange programs in the traditional medicine domain. Public awareness campaigns and initiatives are systematically executed to enlighten the population about traditional medicine's merits and stimulate its widespread embrace.

These initiatives frequently entail the organization of workshops, seminars, and public health campaigns. A significant move occurred in March 2022 when the Government of India inked a deal with the World Health Organization (WHO) to establish the WHO Global Center for Traditional Medicine in Jamnagar, Gujarat, India. It is an international hub of traditional medical knowledge, backed by a substantial investment of USD 250 million from the Indian government, geared toward leveraging the worldwide potential of traditional medicine by merging it with modern science and technology. The overarching goal is to enhance both human health and environmental well-being.

Ayurveda is Dominating India Traditional Medicine Market

The ayurvedic sector plays a dominant role in propelling the expansion of India traditional medicine market. The growth is propelled by several key factors, including a surging demand for genuine ayurvedic medicinal offerings, heightened consumer awareness, and increasing emphasis on health and well-being. In contrast to prescription medications, Ayurvedic products are known for their minimal risk of causing severe side effects while demonstrating efficacy in addressing chronic ailments. India is presented with a remarkable opportunity to harness the economic potential of the

Ayurvedic pharmaceutical industry, driven by a clear purpose and substantial demand, both domestically and internationally. Numerous prominent companies are striving to capitalize on the future growth potential of India traditional medicine market, which will be shaped by the increasing levels of disposable income and the changing lifestyle trends. In January 2023, Dabur India unveiled its commitment to promote Ayurveda among contemporary consumers. They introduced two products, namely the premium sugar-free health revitalizer, called Ratnaprash Sugar-Free and the ayurvedic digestive tonic, known as Aampachak kadha, during the 9th World Ayurveda Congress & International AROGYA EXPO held in Goa.

Sustained Interest in Herbal Goods

Herbal products account for a significant portion of the traditional medicine market in India. Large pharmaceutical corporations in India are steadily establishing a presence in the expanding market for herbal medicines. The development is driven by consumers' increasing preference for high-quality natural treatments associated with well-known brands. The demand for herbal dietary supplements has surged due to consumers embracing natural preventive solutions for various health issues. The shift has gained significant attention in 2020 during the global pandemic, with individuals seeking stress relief and immune system support, consequently driving up the sales of herbal dietary supplements. For instance, in May 2023, Himalaya Wellness, a brand specializing in herbal supplements and plant-based personal care products, launched its Ashwagandha+ supplement range while expanding its Hello product line with three new offerings. One of these additions was Himalaya's Ashwagandha+ Focus, crafted to enhance memory and concentration. This formulation, containing ashwagandha, bacopa, rosemary, and green tea, promotes cognitive function.

Key Players Landscape and Outlook

Pharmaceutical giants are strategically acquiring Indian ayurvedic enterprises in response to shifting consumer preferences causing a great shift in India traditional medicine market. Traditional medicinal systems have experienced a revival in popularity, driven by consumers' growing interest in natural and comprehensive healthcare alternatives. By acquiring well-established ayurvedic companies, pharmaceutical giants can enter this expanding market, presenting an array of herbal and ayurvedic products that resonate with consumers' preferences for natural remedies. The calculated maneuver diversifies pharmaceutical firms' product portfolios and allow them to harness the trust and heritage associated with these local Ayurvedic brands. Hence, they meet the emerging needs of health-conscious consumers who are increasingly exploring alternative and complementary therapeutic options.

In November 2022, Mankind Pharma Ltd. made a significant investment by acquiring a majority stake in Upakarma Ayurveda Pvt Ltd through one of its subsidiaries, for an undisclosed amount. Mankind Pharma's commitment to enhancing healthcare services led to its partnership with Upakarma Ayurveda, which is aimed at meeting the evolving demands of consumers.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. India Traditional Medicine Market Outlook, FY2017-FY2031F

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
  • 4.1.2. By Volume
• 4.2. By System of Medicine
  • 4.2.1. Ayurveda
  • 4.2.2. Yoga
  • 4.2.3. Naturopathy
  • 4.2.4. Unani
  • 4.2.5. Siddha
  • 4.2.6. Homeopathy
• 4.3. By Sub-sectors
  • 4.3.1. Herbal Plants
  • 4.3.2. Nutraceuticals
  • 4.3.3. Cosmeceuticals
  • 4.3.4. Pharmaceuticals
  • 4.3.5. Plant Derivatives
  • 4.3.6. Plant Extracts
• 4.4. By Source
  • 4.4.1. Plants
  • 4.4.2. Animals
  • 4.4.3. Metals
  • 4.4.4. Minerals
• 4.5. By Application
  • 4.5.1. Neurovascular
  • 4.5.2. Cardiovascular
  • 4.5.3. Dermatology
  • 4.5.4. Oncology
  • 4.5.5. Respiratory
  • 4.5.6. Diabetology
  • 4.5.7. Others
• 4.6. Route of Administration
  • 4.6.1. Oral route
  • 4.6.2. Nasal route
  • 4.6.3. Ocular route
  • 4.6.4. Otic route
  • 4.6.5. Cutaneous route
  • 4.6.6. Others
• 4.7. By Distribution Channel
  • 4.7.1. Hospital Pharmacy
  • 4.7.2. Retail Pharmacy
  • 4.7.3. Online Pharmacy
  • 4.7.4. AYUSH Health & Wellness Centre
• 4.8. By Region
  • 4.8.1. North
  • 4.8.2. South
  • 4.8.3. East
  • 4.8.4. West & Central
• 4.9. By Company Market Share (%), FY2023

6. Market Mapping, FY2023

• 6.1. By System of Medicine
• 6.2. By Sub-sectors
• 6.3. By Source
• 6.4. By Application
• 6.5. By Route of Administration
• 6.6. By Distribution Channel
• 6.7. By Region

7. Macro Environment and Industry Structure

• 7.1. Supply Demand Analysis
• 7.2. Import Export Analysis
• 7.3. Value Chain Analysis
• 7.4. PESTEL Analysis
  • 7.4.1. Political Factors
  • 7.4.2. Economic System
  • 7.4.3. Social Implications
  • 7.4.4. Technological Advancements
  • 7.4.5. Environmental Impacts
  • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 7.5. Porter's Five Forces Analysis
  • 7.5.1. Supplier Power
  • 7.5.2. Buyer Power
  • 7.5.3. Substitution Threat
  • 7.5.4. Threat from New Entrant
  • 7.5.5. Competitive Rivalry

8. Market Dynamics

• 8.1. Growth Drivers
• 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

• 9.1. Clinical Trials
• 9.2. Patent Landscape
• 9.3. Regulatory Approvals
• 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

• 10.1. Competition Matrix of Top Five Market Leaders
• 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, FY2023)
• 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
• 10.4. SWOT Analysis (For Five Market Players)
• 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

• 13.1. Himalaya Wellness Company
  • 13.1.1. Company Details
  • 13.1.2. Key Management Personnel
  • 13.1.3. Products & Services
  • 13.1.4. Financials (As reported)
  • 13.1.5. Key Market Focus & Geographical Presence
  • 13.1.6. Recent Developments
• 13.2. Dabur India Ltd.
• 13.3. Patanjali Ayurved Ltd.
• 13.4. Shree Baidyanath Ayurved Bhawan Pvt. Ltd.
• 13.5. Hamdard Laboratories
• 13.6. Dr. Reckeweg & Co.
• 13.7. Dr Willmar Schwabe India Pvt. Ltd.
• 13.8. Ayyebi Dawakhana Unani Pvt. Ltd.
• 13.9. SBL Pvt. Ltd.
• 13.10. Hahnemann Scientific Laboratory
• 13.11. Tamil Nadu Medicinal Plant Farms and Herbal Medicine Corporation Ltd. (TAMPCOL)
• 13.12. The Indian Medical Practitioners Co-operative Pharmacy and Stores Ltd. (IMPCOPS)

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. India Traditional Medicine Market, By Value, In USD Billion, FY2017-FY2031F
• Figure 2. India Traditional Medicine Market, By Volume, In Million Units, FY2017-FY2031F
• Figure 3. India Traditional Medicine Market Share (%), By System of Medicine, FY2017-FY2031F
• Figure 4. India Traditional Medicine Market Share (%), By Sub-sectors, FY2017-FY2031F
• Figure 5. India Traditional Medicine Market Share (%), By Source, FY2017-FY2031F
• Figure 6. India Traditional Medicine Market Share (%), By Application, FY2017-FY2031F
• Figure 7. India Traditional Medicine Market Share (%), By Route of Administration, FY2017-FY2031F
• Figure 8. India Traditional Medicine Market Share (%), By Distribution Channel, FY2017-FY2031F
• Figure 9. India Traditional Medicine Market Share (%), By Region, FY2017-FY2031F
• Figure 10. By System of Medicine Map-Market Size (USD Billion) & Growth Rate (%), FY2023
• Figure 11. By Sub-sectors Map-Market Size (USD Billion) & Growth Rate (%), FY2023
• Figure 12. By Source Map-Market Size (USD Billion) & Growth Rate (%), FY2023
• Figure 13. By Application Map-Market Size (USD Billion) & Growth Rate (%), FY2023
• Figure 14. By Route of Administration Map-Market Size (USD Billion) & Growth Rate (%), FY2023
• Figure 15. By Distribution Channel Map-Market Size (USD Billion) & Growth Rate (%), FY2023
• Figure 16. By Region Map-Market Size (USD Billion) & Growth Rate (%), FY2023